104 related articles for article (PubMed ID: 7692726)
21. Hepatitis C RNA prevalence in a Western European organ donor pool and virus transmission by organ transplantation.
Candinas D; Joller-Jemelka HI; Schlumpf R; Wicki A; Mutimer DJ; Keusch G; Largiadèr F
J Med Microbiol; 1994 Oct; 41(4):220-3. PubMed ID: 7523676
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
[TBL] [Abstract][Full Text] [Related]
23. [Incidence of hepatitis C virus in kidney transplantation recipients].
Catelle A; Edert D; Renoult E; Cao Huu T
Agressologie; 1992; 33 Spec No 2():99-102. PubMed ID: 1340101
[TBL] [Abstract][Full Text] [Related]
24. Detection of antibody to hepatitis C virus by second-generation enzyme immunoassay.
Chaudhary RK; Maclean C
Am J Clin Pathol; 1993 Jun; 99(6):702-4. PubMed ID: 7686716
[TBL] [Abstract][Full Text] [Related]
25. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
[TBL] [Abstract][Full Text] [Related]
27. The impact of hepatitis C virus infection on renal allograft recipients.
Roth D; Zucker K; Cirocco R; DeMattos A; Burke GW; Nery J; Esquenazi V; Babischkin S; Miller J
Kidney Int; 1994 Jan; 45(1):238-44. PubMed ID: 7510350
[TBL] [Abstract][Full Text] [Related]
28. Antibody responses to hepatitis C virus by second-generation immunoassays in a cohort of patients with bleeding disorders.
Hatzakis A; Polychronaki H; Miriagou V; Yannitsiotis A; Chrispeels J; Troonen H; Karafoulidou A; Gialeraki A; Katsouyanni K; Mandalaki T
Vox Sang; 1992; 63(3):204-9. PubMed ID: 1333137
[TBL] [Abstract][Full Text] [Related]
29. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients.
Huang CC; Liaw YF; Lai MK; Chu SH; Chuang CK; Huang JY
Transplantation; 1992 Apr; 53(4):763-5. PubMed ID: 1373534
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C infection in BMT patients.
Kolho E; Ruutu P; Ruutu T
Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.
Chan TM; Lok AS; Cheng IK; Chan RT
Hepatology; 1993 Jan; 17(1):5-8. PubMed ID: 7678575
[TBL] [Abstract][Full Text] [Related]
32. Detection of antibody to hepatitis C virus in renal transplant recipients.
Roth D; Fernandez JA; Burke GW; Esquenazi V; Miller J
Transplantation; 1991 Feb; 51(2):396-400. PubMed ID: 1847250
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of hepatitis C virus markers in Sri Lankan patients with alcoholic cirrhosis.
De Silva HJ; Vitarana T; Ratnatunga N; Breschkin A; Withane N; Kularatne WN
J Gastroenterol Hepatol; 1994; 9(4):381-4. PubMed ID: 7524722
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation.
Pol S; Legendre C; Saltiel C; Carnot F; Bréchot C; Berthelot P; Mattlinger B; Kreis H
J Hepatol; 1992 May; 15(1-2):202-6. PubMed ID: 1324270
[TBL] [Abstract][Full Text] [Related]
35. Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up.
Yousuf M; Nakano Y; Tanaka E; Sodeyama T; Kiyosawa K
Scand J Gastroenterol; 1992 Sep; 27(9):812-6. PubMed ID: 1384112
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a chimpanzee colony for antibodies to hepatitis C virus.
Lanford RE; Notvall L; Barbosa LH; Eichberg JW
J Med Virol; 1991 Jul; 34(3):148-53. PubMed ID: 1717646
[TBL] [Abstract][Full Text] [Related]
37. [Hepatitis C in kidney recipients. Epidemiology and impact on kidney transplantation].
Pol S; Legendre C; Saltiel C; Carnot F; Bréchot C; Berthelot P; Mattlinger B; Kreis H
Presse Med; 1991 Nov; 20(40):2025-7. PubMed ID: 1837117
[TBL] [Abstract][Full Text] [Related]
38. [Anti-HCV serology for screening, diagnosis and surveillance of hepatitis C: role of the immunoblot].
Dubois F; Barin F; Goudeau A
Ann Biol Clin (Paris); 1998; 56(4):417-26. PubMed ID: 9754277
[TBL] [Abstract][Full Text] [Related]
39. Is autoimmune chronic active hepatitis a HCV-related disease?
Magrin S; Craxì A; Fiorentino G; Fabiano C; Provenzano G; Pinzello GB; Palazzo U; Almasio P; Pagliaro L
J Hepatol; 1991 Jul; 13(1):56-60. PubMed ID: 1717543
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance of hepatitis C antibodies in blood donors.
Kolho E; Färkkilä M; Mäkinen J; Krusius T; Naukkarinen R; Ikkala E
J Med Virol; 1994 Jun; 43(2):129-34. PubMed ID: 7521901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
